Pepgen to participate in upcoming investor conferences

Boston--(business wire)--pepgen inc. (nasdaq: pepg), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that management will participate in the following upcoming investor conferences: leerink partners global healthcare conference 2025 (miami, fl) tuesday, march 11, 2025 at 3:00 p.m. et, fireside chat stifel 2025 virtual cns forum wednesda.
PEPG Ratings Summary
PEPG Quant Ranking